Evidence map›Paper›PMID 41971665›Full record

ArticleFrontiers in physiology2026

The selective serotonin reuptake inhibitor sertraline causes ocular toxicity in larvae of zebrafish (

Marwin Jafari, Yann Stehly, Daniela M Pampanin

Abstract read
In one paragraph

Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marwin JafariDepartment of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.
Yann StehlyDepartment of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.
Daniela M PampaninDepartment of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Selective serotonin reuptake inhibitors (SSRIs) are currently the highest prescribed class of antidepressants and are frequently detected in aquatic ecosystems. They act by increasing synaptic concentrations of serotonin, a neurotransmitter which is also involved in neuronal development. A knowledge gap remains regarding the effects of SSRIs on visual function, a process heavily relying on the neuronal system. Methods: To close this knowledge gap, zebrafish ( Results: Visual function was affected after exposure to 100 and 1000 µg/L of SER, while retinal structure was significantly affected after exposure to 1000 µg/L of SER. To study the molecular processes behind these effects, gene expression was assessed, pointing out dysregulation of multiple opsin genes, as well as genes involved in retinoic acid metabolism and eye development, namely Discussion: The present study points out the ability of SER to cause adverse effects to visual function, a key process for early life stage fish survival. However, these effects were detected at exposure concentrations exceeding the environmental one, thus not representing an environmental threat.

Indexed as

antidepressantaquatic toxicologyecotoxicologyeye development and functionhistologyzebrafish

Identifiers

PMID41971665
PMCPMC13066282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.